Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Acquires Cell Sorting System from Propel Labs

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has acquired a new cell sorting system from Propel Labs for an undisclosed amount, the Hercules, Calif.-based firm announced today.

Bio-Rad plans to begin shipping the benchtop sorting flow cytometer, called the S3 Cell Sorter, in January.

While cell sorting instruments are usually found in shared research service facilities because of their size, complexity, and maintenance, the S3 Cell Sorter will allow researchers to bring their cell sorting research onto their benchtops, Bio-Rad said.

"With this acquisition, we benefit from Propel Labs' years of expertise in cell sorting," Brad Crutchfield, president of the Life Science Group at Bio-Rad, said in a statement. "The S3 Cell Sorter fits in well with Bio-Rad's existing product workflow and will offer researchers greater access to targeting specific cells in their experiments and ultimately increasing the sensitivity of their assays."

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.